Harbin Pharmaceutical

Harbin Pharmaceutical Group Co. said that it is considering an overseas IPO. The Chinese drug-maker already is listed in < ?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" />Shanghai, and is controlled by a consortium led by Warburg Pincus. < ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />